Canada • TSX Venture Exchange • TSX-V:TELO • CA87975M2085
We assign a fundamental rating of 0 out of 10 to TELO. TELO was compared to 23 industry peers in the Biotechnology industry. TELO may be in some trouble as it scores bad on both profitability and health. TELO has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -446.15% | ||
| ROE | N/A | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -82.17 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 0 / 10 to TELO.CA.
ChartMill assigns a valuation rating of 0 / 10 to TELO GENOMICS CORP (TELO.CA). This can be considered as Overvalued.
TELO GENOMICS CORP (TELO.CA) has a profitability rating of 0 / 10.